ArticleClinical, cosmetic and investigational dermatology2023

Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection.

Luca Potestio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.